Best Options Strategy for ALNY
Looking for the best options strategy for Alnylam Pharmaceuticals, Inc. (ALNY)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live ALNY option chain right now, and a simple map from your view on ALNY to the strategy that fits it. Model any of them in the calculator before you trade.
About ALNY
Alnylam Pharmaceuticals, Inc. (ALNY) is a major company in Biotechnology. Options traders on ALNY tend to watch , since these can drive large moves in the share price.
About Alnylam Pharmaceuticals, Inc.
# About Alnylam Pharmaceuticals, Inc.
Alnylam develops and sells medicines built on RNA interference technology, a mechanism that silences disease-causing genes. The company has marketed six drugs across multiple therapeutic areas: ONPATTRO and AMVUTTRA for hereditary transthyretin amyloidosis, Leqvio for high cholesterol, Qfitlia for hemophilia, GIVLAARI for acute porphyria, and OXLUMO for primary hyperoxaluria. Beyond these approved treatments, Alnylam maintains an extensive pipeline spanning late-stage development, with Phase 3 candidates addressing amyloidosis, hypertension, myasthenia gravis, and viral hepatitis among others, plus dozens of earlier-stage programs exploring applications in metabolic diseases, neurological disorders, bleeding conditions, and cancer.
Alnylam generates revenue primarily through product sales in the United States, Europe, and international markets. The company also enters strategic partnerships with major pharmaceutical firms—including Regeneron, Roche, Sanofi, and Novartis—which provide funding, co-development resources, and commercialization support. This partnership model helps offset the substantial costs of drug development while expanding…
Today's top-scoring strategy for ALNY
Our engine ranks defined-risk strategies on the live ALNY chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Sell | 1× | CALL | $245 | $2.92 |
| Buy | 1× | CALL | $270 | $0.25 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Strategy analysis
Greeks vs price
Price × volatility (today)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $284 | −$1,994 | −$1,889 | −$1,791 | −$1,704 | −$1,628 |
| $273 | −$1,672 | −$1,569 | −$1,485 | −$1,417 | −$1,359 |
| $262 | −$1,165 | −$1,125 | −$1,093 | −$1,066 | −$1,044 |
| $250 | −$582 | −$630 | −$664 | −$689 | −$708 |
| $239 | −$106 | −$200 | −$276 | −$339 | −$389 |
| $227 | $156 | $82 | $7 | −$62 | −$124 |
| $216 | $246 | $214 | $170 | $119 | $66 |
| $205 | $265 | $257 | $240 | $214 | $181 |
| $193 | $267 | $266 | $262 | $252 | $237 |
| $182 | $267 | $267 | $266 | $264 | $259 |
| $171 | $267 | $267 | $267 | $267 | $265 |
Illustrative example at ALNY's latest available price, computed with the same engine as the tool. Live option fills and the real IV skew refresh during US market hours.
Implied volatility
ALNY is currently trading with moderate implied volatility, broadly in line with other large-cap stocks. On the options we scanned that was around 32% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on ALNY currently price in about 32% implied volatility, versus roughly 107% the stock has actually realised over the past month. That makes options relatively cheap — an edge for strategies that buy premium, such as long calls, long puts and debit spreads.
ALNY's IV Rank is 0/100: implied volatility sits 0% of the way between its 21-day low (32%) and high (60%), and is above 0% of recorded days. Premium is historically cheap, which favours net-debit strategies like long options and debit spreads.
Off that volatility, the options market is pricing a move of about ±$22.3 (±10%) in ALNY by 2026-09-18 — a range of roughly $205 to $250. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, downside puts on ALNY trade at a higher implied volatility than upside calls — the market is paying up for crash protection. That skew favours selling put spreads or buying calls over symmetric trades.
ALNY insider trading activity (SEC Form 4)
Open-market insider transactions at ALNY over roughly the last six months, from SEC Form 4 filings. Open-market buys are the rarer, more telling signal — routine selling under pre-arranged plans is common, so read a net-selling figure with that in mind.
| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| PYOTT DAVID E I | Sell | 17 | $5K | 2026-06-01 |
| PYOTT DAVID E I | Sell | 495 | $149K | 2026-06-01 |
| PYOTT DAVID E I | Sell | 1,222 | $366K | 2026-06-01 |
| PYOTT DAVID E I | Sell | 1,175 | $351K | 2026-06-01 |
| PYOTT DAVID E I | Sell | 921 | $274K | 2026-06-01 |
| McLaughlin Melissa | Sell | 199 | $66K | 2026-04-06 |
Source: SEC Form 4 filings via Finnhub. Open-market purchases (P) and sales (S) only — grants, option exercises, gifts and tax withholding are excluded. Informational context, not investment advice.
Earnings & IV crush
ALNY's next earnings report is due around October 29, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Key figures
- Market cap
- $30.6B
- Beta (vs market)
- 0.28
- 52-week range
- $197.81–$495.55 (10% up the range)
- Short interest
- 5.8% of float · 3.6 days to cover
How to choose an options strategy for ALNY
Start with your outlook on ALNY, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while ALNY stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open ALNY in the free calculator →
Frequently asked questions
What is the best options strategy for ALNY?
It depends on your outlook. Bullish traders often use a long call or bull call spread on ALNY; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are ALNY options liquid enough to trade?
Alnylam Pharmaceuticals, Inc. (ALNY) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade ALNY options?
Buying a single ALNY call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade ALNY or any security. Do your own research.
What does Alnylam Pharmaceuticals, Inc. do?
Alnylam Pharmaceuticals, Inc. (ALNY) operates in the Biotechnology industry. The "About Alnylam Pharmaceuticals, Inc." section above gives a fuller picture of what the company does and how it earns money.
Does Alnylam Pharmaceuticals, Inc. pay a dividend?
We don't show a confirmed dividend yield for Alnylam Pharmaceuticals, Inc. here, so treat it as uncertain: before writing calls, check its current dividend and ex-dividend date with your broker — an approaching ex-dividend date can trigger early assignment on in-the-money short calls.
When does Alnylam Pharmaceuticals, Inc. next report earnings?
Alnylam Pharmaceuticals, Inc.'s next earnings are expected around October 29, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Price trend
Tickers related to ALNY
Comparing ALNY with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 675 West Kendall Street, Henri A. Termeer Square, Cambridge, MA, 02142, United States
- Industry
- Biotechnology
- Employees
- 2,500
- CEO
- Dr. Yvonne L. Greenstreet M.B.A., M.D.
- Phone
- 617 551 8200
- Website
- www.alnylam.com
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.